User:Mr. Ibrahem/Ipilimumab

Ipilimumab, sold under the brand name Yervoy, is a medication used to treat melanoma, renal cell cancer, mesothelioma, and non-small cell lung cancer (NSCLC). It is often used together with nivolumab. It is given by gradual injection into a vein.

Common side effects include rash, itchiness, tiredness, diarrhea, nausea, fever, thyroid problems, shortness of breath, liver inflammation, and abdominal pain. Other side effects may include intestinal inflammation, toxic epidermal necrolysis, and neuropathy. It is a monoclonal antibody that attaches to and blocks CTLA-4 which increases T cell activity against cancer.

Ipilimumab was approved for medical use in the United States and Europe in 2011. In the United Kingdom it costs about £15,000 for 200 mg as of 2021. In the United States this amount costs about 32,300 USD.